Article
De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
Antiviral therapy - 1 Jan 2011
Ueda Yoshihide, Marusawa Hiroyuki, Egawa Hiroto, Okamoto Shinya, Ogura Yasuhiro, Oike Fumitaka, Nishijima Norihiro, Takada Yasutsugu, Uemoto Shinji, Chiba Tsutomu
Abstract excerpt
BACKGROUND: De novo activation of HBV occurs after liver transplantation from hepatitis B surface antigen (HBsAg)-negative and hepatitis B core antibody (anti-HBc)-positive donors, even under hepatitis B immunoglobulin (HBIG) prophylaxis. One reason for the activation of HBV is the emergence of HBV with escape mutations from hepatitis B surface antibody (anti-HBs). The aim of this study is to clarify the clinical...
Topics
Join the communities discussing this publication.